These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18514220)

  • 21. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human monoclonal antibodies.
    Cole SP; Campling BG; Atlaw T; Kozbor D; Roder JC
    Mol Cell Biochem; 1984 Jun; 62(2):109-20. PubMed ID: 6087121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
    Glaser RW; Jahn S; Grunow R
    Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in the basic technology of electrofusion for generation of antibody-producing hybridomas.
    Ohnishi K; Chiba J; Goto Y; Tokunaga T
    J Immunol Methods; 1987 Jun; 100(1-2):181-9. PubMed ID: 3110294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient generation of stable antibody forming hybridoma cells by electrofusion.
    Schmitt JJ; Zimmermann U; Neil GA
    Hybridoma; 1989 Feb; 8(1):107-15. PubMed ID: 2925206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An extreme strategy for the production of hybridoma.
    Golestani R; Pourfathollah AA; Moazzeni SM
    Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
    Kozbor D; Lagarde AE; Roder JC
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6651-5. PubMed ID: 6292911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus.
    Grunow R; Jahn S; Porstmann T; Kiessig SS; Steinkellner H; Steindl F; Mattanovich D; Gürtler L; Deinhardt F; Katinger H
    J Immunol Methods; 1988 Feb; 106(2):257-65. PubMed ID: 2828478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A human myeloma cell line suitable for the generation of human monoclonal antibodies.
    Karpas A; Dremucheva A; Czepulkowski BH
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1799-804. PubMed ID: 11172031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
    Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
    Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
    [No Abstract]   [Full Text] [Related]  

  • 33. [Human hybridoma neutralizing antibodies to the herpes simplex virus].
    Kushch AA; Tugizov ShM; Terletskaia EN; Posevaia TA; Nikitina AA; L'vov ND; Barinskiĭ IF
    Vopr Virusol; 1992; 37(5-6):264-6. PubMed ID: 1337804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
    Tokunaga T; Chiba J; Ohnishi K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel method for making human monoclonal antibodies.
    Fraussen J; Vrolix K; Martinez-Martinez P; Losen M; Meulemans E; De Baets MH; Stinissen P; Somers V
    J Autoimmun; 2010 Sep; 35(2):130-4. PubMed ID: 20732843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human and chimpanzee monoclonal antibodies.
    Van Meel FC; Steenbakkers PG; Oomen JC
    J Immunol Methods; 1985 Jun; 80(2):267-76. PubMed ID: 2989374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly efficient procedure for production of human monoclonal antibodies: establishment of hybrids between Epstein-Barr virus-transformed B lymphocytes and heteromyeloma cells by use of GIT culture medium.
    Kudo T; Asao A; Tachibana T
    Tohoku J Exp Med; 1988 Apr; 154(4):345-55. PubMed ID: 2847359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of human-human and human-mouse hybridomas secreting Rh(D)-specific monoclonal antibodies.
    MacDonald G; Primrose S; Biggins K; Bowman JM; Berczi I; Friesen AD; Sehon AH
    Scand J Immunol; 1987 May; 25(5):477-83. PubMed ID: 3035706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.